Cargando…
Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
Chagas’ disease, or American trypanosomosiasis, has been the most relevant illness produced by protozoa in Latin America. Synthetic medicinal chemistry efforts have provided an extensive number of chemodiverse hits at the “active-to-hit” stage. However, only a more limited number of these have been...
Autores principales: | Cerecetto, Hugo, González, Mercedes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034012/ https://www.ncbi.nlm.nih.gov/pubmed/27713281 http://dx.doi.org/10.3390/ph3040810 |
Ejemplares similares
-
New hits as phase II enzymes inducers from a focused library with heteroatom–heteroatom and Michael-acceptor motives
por: Cabrera, Mauricio, et al.
Publicado: (2015) -
Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment
por: Aguilera, Elena, et al.
Publicado: (2018) -
Drug Discovery for Chagas Disease: Impact of Different Host Cell Lines on Assay Performance and Hit Compound Selection
por: Franco, Caio Haddad, et al.
Publicado: (2019) -
A mini review on pyridoacridines: Prospective lead compounds in medicinal chemistry
por: Sharma, Vikas, et al.
Publicado: (2015) -
Phenocopy – A Strategy to Qualify Chemical Compounds during Hit-to-Lead and/or Lead Optimization
por: Baum, Patrick, et al.
Publicado: (2010)